BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24658463)

  • 1. Underlying mechanism of antimicrobial activity of chitosan microparticles and implications for the treatment of infectious diseases.
    Jeon SJ; Oh M; Yeo WS; Galvão KN; Jeong KC
    PLoS One; 2014; 9(3):e92723. PubMed ID: 24658463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of Escherichia coli O157:H7 shedding in cattle by addition of chitosan microparticles to feed.
    Jeong KC; Kang MY; Kang J; Baumler DJ; Kaspar CW
    Appl Environ Microbiol; 2011 Apr; 77(8):2611-6. PubMed ID: 21335379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan Microparticles Exert Broad-Spectrum Antimicrobial Activity against Antibiotic-Resistant Micro-organisms without Increasing Resistance.
    Ma Z; Kim D; Adesogan AT; Ko S; Galvao K; Jeong KC
    ACS Appl Mater Interfaces; 2016 May; 8(17):10700-9. PubMed ID: 27057922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of chitosan-derived nanoparticles to enhance antimicrobial activity against foodborne pathogen Escherichia coli O157:H7.
    Garrido-Maestu A; Ma Z; Paik SY; Chen N; Ko S; Tong Z; Jeong KC
    Carbohydr Polym; 2018 Oct; 197():623-630. PubMed ID: 30007655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Nano-Antimicrobial Polymer Engineered with Chitosan Nanoparticles and Bioactive Peptides as Promising Food Biopreservative Effective against Foodborne Pathogen
    Kuang M; Yu H; Qiao S; Huang T; Zhang J; Sun M; Shi X; Chen H
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance patterns of Shiga toxin-producing Escherichia coli O157:H7 and O157:H7- from different origins.
    Srinivasan V; Nguyen LT; Headrick SI; Murinda SE; Oliver SP
    Microb Drug Resist; 2007; 13(1):44-51. PubMed ID: 17536933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of chitosan coating containing ZnO nanoparticles against E. coli O157:H7 on the surface of white brined cheese.
    Al-Nabulsi A; Osaili T; Sawalha A; Olaimat AN; Albiss BA; Mehyar G; Ayyash M; Holley R
    Int J Food Microbiol; 2020 Dec; 334():108838. PubMed ID: 32896745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of chitosan microparticles for treatment of metritis and in vivo evaluation of broad spectrum antimicrobial activity in cow uteri.
    Jeon SJ; Ma Z; Kang M; Galvão KN; Jeong KC
    Biomaterials; 2016 Dec; 110():71-80. PubMed ID: 27710834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Killing of Shiga Toxin-Producing
    Ma Z; Kang M; Meng S; Tong Z; Yoon SD; Jang Y; Jeong KC
    ACS Appl Mater Interfaces; 2020 Apr; 12(16):18332-18341. PubMed ID: 32239905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
    Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.
    Doavi T; Mousavi SL; Kamali M; Amani J; Fasihi Ramandi M
    Iran Biomed J; 2016; 20(2):97-108. PubMed ID: 26724233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protozoan Predation of Escherichia coli O157:H7 Is Unaffected by the Carriage of Shiga Toxin-Encoding Bacteriophages.
    Schmidt CE; Shringi S; Besser TE
    PLoS One; 2016; 11(1):e0147270. PubMed ID: 26824472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the transcription of the Escherichia coli O157:H7 genes coding for shiga-like toxins and intimin, and its potential use in the treatment of human infection with the bacterium.
    Matar GM; Rahal E
    Ann Trop Med Parasitol; 2003 Apr; 97(3):281-7. PubMed ID: 12803859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of decontamination efficacy of antimicrobial treatments for beef trimmings against Escherichia coli O157:H7 and 6 non-O157 Shiga toxin-producing E. coli serogroups.
    Geornaras I; Yang H; Manios S; Andritsos N; Belk KE; Nightingale KK; Woerner DR; Smith GC; Sofos JN
    J Food Sci; 2012 Sep; 77(9):M539-44. PubMed ID: 22897565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric Nanohybrids Engineered by Chitosan Nanoparticles and Antimicrobial Peptides as Novel Antimicrobials in Food Biopreservatives: Risk Assessment and Anti-Foodborne Pathogen
    Yu HT; Zhang JQ; Sun MC; Chen H; Shi XM; You FP; Qiao SY
    J Agric Food Chem; 2022 Oct; 70(39):12535-12549. PubMed ID: 36153996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater diversity of Shiga toxin-encoding bacteriophage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from humans.
    Besser TE; Shaikh N; Holt NJ; Tarr PI; Konkel ME; Malik-Kale P; Walsh CW; Whittam TS; Bono JL
    Appl Environ Microbiol; 2007 Feb; 73(3):671-9. PubMed ID: 17142358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of integron-mediated antibiotic resistance among Shiga toxin-producing Escherichia coli isolates.
    Zhao S; White DG; Ge B; Ayers S; Friedman S; English L; Wagner D; Gaines S; Meng J
    Appl Environ Microbiol; 2001 Apr; 67(4):1558-64. PubMed ID: 11282605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antimicrobial Effect of a Commercial Mixture of Natural Antimicrobials Against Escherichia coli O157:H7.
    Stratakos AC; Linton M; Ward P; Campbell M; Kelly C; Pinkerton L; Stef L; Pet I; Stef D; Iancu T; Theodoridou K; Gundogdu O; Corcionivoschi N
    Foodborne Pathog Dis; 2019 Feb; 16(2):119-129. PubMed ID: 30277811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB/c mice.
    Rahal EA; Kazzi N; Sabra A; Abdelnoor AM; Matar GM
    Ann Clin Microbiol Antimicrob; 2011 Sep; 10():34. PubMed ID: 21906403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.